Which members of Congress traded AbbVie ABBV recently?

The latest reported trades: Rep. Pete Sessions, full sale on 09/14 (reported 09/18), Sen. Alan Armstrong, purchase on 03/27 (reported 07/21), Rep. Josh Gottheimer, full sale on 05/05 (reported 06/03), Rep. Julie Johnson, full sale on 25/12/18 (reported 01/15) and Rep. Julia Letlow, full sale on 25/12/08 (reported 01/13).

Stocks

AbbVie ABBV

Health care sectorNYSE

What to see in AbbVie now

Is Wall Street adding or cutting?+106

4,210 13F filers hold it · +106 against the quarter before · shares held +2.7%

Holdings of 06/30

Are members of Congress buying or selling?2

2 members of Congress traded it in 90 days · 1 purchases · 1 sales

Reported 09/18

How much more do Koreans hold through ETFs?$94.6M

Koreans hold $94.6M more through 6 ETFs

Holdings of 06/30

Close: $261.94; 09/30 close
Day change: −0.5%; vs previous close
Volume: 126,056; −44.0% vs 30-day average
52-week range: $191.33$269.25
1-year return: +13.1%; vs the close a year ago
Market cap: $462.9B; 1,767,117,285 shares · reported 07/27

Company

Exchange: NYSE
Sector: Health care
Industry: Pharmaceutical Preparations
Headquarters: North Chicago, Illinois
Fiscal year end: 12/31
Next earnings: 08/28, estimated

2 members of Congress traded it in 90 days · 1 purchases · 1 salesReported 09/18

Congress trades

	Trade
Pete SessionsRepresentative · Republican · TX	Full saleSelf	$15K–$50K	09/14	09/184 days later
Alan ArmstrongSenator · Republican · OK	BuySelf	$15K–$50K	03/27	07/21116 days later
Josh GottheimerRepresentative · Democrat · NJ	Full saleJoint	$1K–$15K	05/05	06/0329 days later
Julie JohnsonRepresentative · Democrat · TX	Full saleJoint	$1K–$15K	25/12/18	01/1528 days later
Julia LetlowRepresentative · Republican · LA	Full saleSelf	$1K–$15K	25/12/08	01/1336 days later

All Congress trades in AbbVie

Lobbying

AbbVie lobbying, last 8 quarters

Reported 07/20

AbbVie lobbying, last 8 quarters
Quarter	Amount	Reports
Q4 2024	$1.5M	9
Q1 2025	$2.6M	9
Q2 2025	$1.7M	10
Q3 2025	$1.6M	10
Q4 2025	$1.9M	10
Q1 2026	$2.8M	12
Q2 2026	$1.7M	12
Q3 2026	$0	0

Main issuesHealth issuesTaxationMedicare and Medicaid

Filed as Abbvie

See all of AbbVie's lobbying

Price

$261.94Day −0.5%1 year +13.1%

26-week trading

Members of Congress reported 2 trades in AbbVie ABBV in the past 90 days (1 purchase, 1 sale).

Common questions

Which members of Congress traded AbbVie ABBV recently?: The latest reported trades: Rep. Pete Sessions, full sale on 09/14 (reported 09/18), Sen. Alan Armstrong, purchase on 03/27 (reported 07/21), Rep. Josh Gottheimer, full sale on 05/05 (reported 06/03), Rep. Julie Johnson, full sale on 25/12/18 (reported 01/15) and Rep. Julia Letlow, full sale on 25/12/08 (reported 01/13).